A pilot study of Taxotere [docetaxel] combined with Xeloda [capecitabine] in the treatment of metastatic breast cancer.

Trial Profile

A pilot study of Taxotere [docetaxel] combined with Xeloda [capecitabine] in the treatment of metastatic breast cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Feb 2012

At a glance

  • Drugs Capecitabine; Docetaxel
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
    • 13 Feb 2012 Actual patient number (18) added as reported by ClinicalTrials.gov.
    • 13 Feb 2012 Actual end date (1 Jan 2006) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top